Genome Analysis Across Populations in Inflammatory Bowel Disease

Abroad (travel likely)Recruiting

Conditions

Ulcerative Colitis · Healthy · Crohn Disease · Inflammatory Bowel Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sinai Health System, Toronto, Ontario, Canada
Contact: Study coordinator (Joanne Stempak, MSc) · joanne.stempak@sinaihealth.ca · 4165864800
Contact: Study coordinator (Jenny Lee, MKin) · IBD.research@sinaihealth.ca · 4165864800

Study leads

Mark Silverberg, MD PhD
Principal Investigator
Sinai Health System

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Ankylosing Spondylitis · Autoimmune Disease · Crohn Disease

Abroad (travel likely)Recruiting

Houston, United States

Predictors of Prognosis in IBD Patients

Inflammatory Bowel Diseases · Ulcerative Colitis · Crohn Disease

Abroad (travel likely)Recruiting

Seongnam-si, South Korea

Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study

Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis

Abroad (travel likely)Recruiting

Coventry, United Kingdom · Newcastle upon Tyne, United Kingdom

IBD Strong Peer2Peer for Self-Management of Psychological Distress

Inflammatory Bowel Diseases · Ulcerative Colitis · Crohn Disease

Abroad (travel likely)Recruiting

Halifax, Canada